Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Julie-An M. Talano MD

Julie-An M. Talano MD

Associate Professor

Institution: Medical College of Wisconsin
Department: Pediatrics
Division: Hematology and Oncology - Pediatrics
Program: Oncology

Member of the Cancer Center

Research Experience

  • Bone Marrow Transplantation
  • Hematopoietic Stem Cell Transplantation
  • Lymphohistiocytosis, Hemophagocytic
  • Clinical Expertise

  • Bone Marrow Transplantation
  • Lymphohistiocytosis, Hemophagocytic
  • Publications

  • Usual and Unusual Manifestations of Familial Hemophagocytic Lymphohistiocytosis and Langerhans Cell Histiocytosis. (Erker C, Harker-Murray P, Talano JA) Pediatr Clin North Am 2017 Feb;64(1):91-109 PMID: 27894453 11/30/2016
  • Salvage therapy for refractory hemophagocytic lymphohistiocytosis: A review of the published experience. (Marsh RA, Jordan MB, Talano JA, Nichols KE, Kumar A, Naqvi A, Vaiselbuh SR, Histiocyte Society Salvage Therapy Working Group) Pediatr Blood Cancer 2017 Apr;64(4) PMID: 27786410 10/28/2016
  • Successful treatment of recurrent CNS disease post-bone marrow transplant in children with familial hemophagocytic lymphohistiocytosis. (Bock AM, LeVeque M, Camitta B, Talano JA) Pediatr Blood Cancer 2016 Dec;63(12):2154-2158 PMID: 27565627 10/21/2016
  • Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience. (Morillo-Gutierrez B, Beier R, Rao K, Burroughs L, Schulz A, Ewins AM, Gibson B, Sedlacek P, Krol L, Strahm B, Zaidman I, Kalwak K, Talano JA, Woolfrey A, Fraser C, Meyts I, Müller I, Wachowiak J, Bernardo ME, Veys P, Sykora KW, Gennery AR, Slatter M) Blood 2016 Jul 21;128(3):440-8 PMID: 27216217 PMCID: PMC4957165 05/25/2016
  • Curative treatment for severe sickle cell disease: allogeneic transplantation. (Oshrine B, Talano JA) Clin Adv Hematol Oncol 2015 Apr;13(4):249-56 PMID: 26352583 09/10/2015
  • Transplant Outcomes for Children with T Cell Acute Lymphoblastic Leukemia in Second Remission: A Report from the Center for International Blood and Marrow Transplant Research. (Burke MJ, Verneris MR, Le Rademacher J, He W, Abdel-Azim H, Abraham AA, Auletta JJ, Ayas M, Brown VI, Cairo MS, Chan KW, Diaz Perez MA, Dvorak CC, Egeler RM, Eldjerou L, Frangoul H, Guilcher GMT, Hayashi RJ, Ibrahim A, Kasow KA, Leung WH, Olsson RF, Pulsipher MA, Shah N, Shah NN, Thiel E, Talano JA, Kitko CL) Biol Blood Marrow Transplant 2015 Dec;21(12):2154-2159 PMID: 26327632 PMCID: PMC4654112 09/04/2015
  • Smoothing the crescent curve: sickle cell disease. (Talano JA, Cairo MS) Hematology Am Soc Hematol Educ Program 2014 Dec 05;2014(1):468-74 PMID: 25696896 02/20/2015
  • Treosulfan-based conditioning and hematopoietic cell transplantation for nonmalignant diseases: a prospective multicenter trial. (Burroughs LM, Nemecek ER, Torgerson TR, Storer BE, Talano JA, Domm J, Giller RH, Shimamura A, Delaney C, Skoda-Smith S, Thakar MS, Baker KS, Rawlings DJ, Englund JA, Flowers ME, Deeg HJ, Storb R, Woolfrey AE) Biol Blood Marrow Transplant 2014 Dec;20(12):1996-2003 PMID: 25196857 PMCID: PMC4324724 09/10/2014
  • Hematopoietic stem cell transplantation for sickle cell disease: state of the science. (Talano JA, Cairo MS) Eur J Haematol 2015 May;94(5):391-9 PMID: 25200500 09/10/2014
  • Sequential myeloablative autologous stem cell transplantation and reduced intensity allogeneic hematopoietic cell transplantation is safe and feasible in children, adolescents and young adults with poor-risk refractory or recurrent Hodgkin and non-Hodgkin lymphoma. (Satwani P, Jin Z, Martin PL, Bhatia M, Garvin JH, George D, Chaudhury S, Talano J, Morris E, Harrison L, Sosna J, Peterson M, Militano O, Foley S, Kurtzberg J, Cairo MS) Leukemia 2015 Feb;29(2):448-55 PMID: 24938649 06/19/2014
  • New frontiers in pediatric Allo-SCT. (Talano JM, Pulsipher MA, Symons HJ, Militano O, Shereck EB, Giller RH, Hancock L, Morris E, Cairo MS) Bone Marrow Transplant 2014 Sep;49(9):1139-45 PMID: 24820213 PMCID: PMC4439009 05/14/2014
  • Allogeneic human mesenchymal stem cell therapy (remestemcel-L, Prochymal) as a rescue agent for severe refractory acute graft-versus-host disease in pediatric patients. (Kurtzberg J, Prockop S, Teira P, Bittencourt H, Lewis V, Chan KW, Horn B, Yu L, Talano JA, Nemecek E, Mills CR, Chaudhury S) Biol Blood Marrow Transplant 2014 Feb;20(2):229-35 PMID: 24216185 11/13/2013
  • The use of novel Therakos™ Cellex® for extracorporeal photopheresis in treatment of graft-versus-host disease in paediatric patients. (Rangarajan HG, Punzalan RC, Camitta BM, Talano JA) Br J Haematol 2013 Nov;163(3):357-64 PMID: 23961954 08/22/2013
  • Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens. (Chellapandian D, Das R, Zelley K, Wiener SJ, Zhao H, Teachey DT, Nichols KE, EBV-HLH Rituximab Study Group) Br J Haematol 2013 Aug;162(3):376-82 PMID: 23692048 PMCID: PMC3776423 05/23/2013
  • Clinical outcomes of children receiving intensive cardiopulmonary support during hematopoietic stem cell transplant. (Duncan CN, Lehmann LE, Cheifetz IM, Greathouse K, Haight AE, Hall MW, Herschberger A, Hill KS, Moffet JR, Morrison RR, Norris AL, Petrovic A, Spear DA, Steiner ME, Talano JA, Tamburro RF, Wagner J, McArthur J, Pediatric Acute Lung Injury and Sepsis (PALISI) Network) Pediatr Crit Care Med 2013 Mar;14(3):261-7 PMID: 23392372 02/09/2013
  • Monitoring and prevention of relapse after allogeneic hematopoietic cell transplantation for myeloid malignancies. (Bacher U, Talano JA, Bishop MR) Biol Blood Marrow Transplant 2012 Jan;18(1 Suppl):S62-73 PMID: 22226115 01/18/2012
  • Allogeneic cellular and autologous stem cell therapy for sickle cell disease: 'whom, when and how'. (Freed J, Talano J, Small T, Ricci A, Cairo MS) Bone Marrow Transplant 2012 Dec;47(12):1489-98 PMID: 22179556 12/20/2011
  • Treatment of recurrent CNS disease post-bone marrow transplant in familial HLH. (Rangarajan HG, Grochowski D, Mulberry MF, Gheorghe G, Camitta BM, Talano JA) Pediatr Blood Cancer 2012 Jul 15;59(1):189-90 PMID: 21755594 07/15/2011
  • Association of Crohn's disease, thiopurines, and primary epstein-barr virus infection with hemophagocytic lymphohistiocytosis. (Biank VF, Sheth MK, Talano J, Margolis D, Simpson P, Kugathasan S, Stephens M) J Pediatr 2011 Nov;159(5):808-12 PMID: 21722918 PMCID: PMC3191286 07/05/2011
  • Delayed hemolytic transfusion reaction in children with sickle cell disease. (de Montalembert M, Dumont MD, Heilbronner C, Brousse V, Charrara O, Pellegrino B, Piguet C, Soussan V, Noizat-Pirenne F) Haematologica 2011 Jun;96(6):801-7 PMID: 21330322 PMCID: PMC3105640 02/19/2011
  • Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (Prochymal™) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study. (Prasad VK, Lucas KG, Kleiner GI, Talano JA, Jacobsohn D, Broadwater G, Monroy R, Kurtzberg J) Biol Blood Marrow Transplant 2011 Apr;17(4):534-41 PMID: 20457269 05/12/2010
  • Focal nodular hyperplasia in pediatric allogeneic hematopoietic cell transplant: case series. (Anderson L, Gregg D, Margolis D, Casper J, Talano J) Bone Marrow Transplant 2010 Aug;45(8):1357-9 PMID: 20140023 02/09/2010
  • Antiviral responses following L-leucyl-L-leucine methyl esther (LLME)-treated lymphocyte infusions: graft-versus-infection without graft-versus-host disease. (Filicko-O'Hara J, Grosso D, Flomenberg PR, Friedman TM, Brunner J, Drobyski W, Ferber A, Kakhniashvili I, Keever-Taylor C, Mookerjee B, Talano JA, Wagner JI, Korngold R, Flomenberg N) Biol Blood Marrow Transplant 2009 Dec;15(12):1609-19 PMID: 19744572 PMCID: PMC2783272 09/12/2009
  • Severe hypercholesterolemia mediated by lipoprotein X in a pediatric patient with chronic graft-versus-host disease of the liver. (Zidan H, Lo S, Wiebe D, Talano J, Alemzadeh R) Pediatr Blood Cancer 2008 Jun;50(6):1280-1 PMID: 18286546 02/21/2008
  • Voriconazole-induced blistering in the setting of graft versus host disease: A report of 2 patients. (Conlon JD, Dauenhauer M, Tonkovic-Capin V, Talano J, Margolis D, Drolet BA, Fairley JA) J Am Acad Dermatol 2008 Mar;58(3):484-7 PMID: 18280346 02/19/2008
  • Captopril to mitigate chronic renal failure after hematopoietic stem cell transplantation: a randomized controlled trial. (Cohen EP, Irving AA, Drobyski WR, Klein JP, Passweg J, Talano JA, Juckett MB, Moulder JE) Int J Radiat Oncol Biol Phys 2008 Apr 01;70(5):1546-51 PMID: 18029109 PMCID: PMC2386758 11/22/2007
  • Recent molecular and cellular advances in pediatric bone marrow transplantation. (Talano JA, Margolis DA) Pediatr Clin North Am 2006 Aug;53(4):685-98 PMID: 16872999 07/29/2006
  • Alternative donor bone marrow transplant for children with Philadelphia chromosome ALL. (Talano JM, Casper JT, Camitta BM, Keever-Taylor CA, Murray KJ, Eapen M, Pierce KL, Margolis DA) Bone Marrow Transplant 2006 Jan;37(2):135-41 PMID: 16273115 11/08/2005
  • Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease. (Talano JA, Hillery CA, Gottschall JL, Baylerian DM, Scott JP) Pediatrics 2003 Jun;111(6 Pt 1):e661-5 PMID: 12777582 06/05/2003
  • Long-term follow-up of children with fever of unknown origin. (Talano JA, Katz BZ) Clin Pediatr (Phila) 2000 Dec;39(12):715-7 PMID: 11156069 01/13/2001
  • Inhibition of human type IV collagenase by a highly conserved peptide sequence derived from its prosegment. (Stetler-Stevenson WG, Talano JA, Gallagher ME, Krutzsch HC, Liotta LA) Am J Med Sci 1991 Sep;302(3):163-70 PMID: 1656751 09/01/1991
  • Last update: 09/14/2017
    jenkins-FCD Prod-132 e0edc266de37dd13c3a3aec79eb87f3c7abc6fa4